Endo International Ordinary Shares reported $2.05B in Current Assets for its third fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Current Assets Change
Amarin AMRN:US USD 686.52M 32.6M
Ani Pharmaceuticals ANIP:US USD 309.38M 13.02M
Bristol Myers Squibb BMY:US USD 26.8B 3.39B
Coherus Biosciences CHRS:US USD 448.28M 1.49M
Eli Lilly And LLY:US USD 17.64B 524.7M
Endo International Ordinary Shares ENDP:US USD 2.05B 145.74M
Heron Therapeutics HRTX:US USD 223.8M 29.6M
Hikma Pharmaceutical HIK:LN USD 2.14B 50M
Horizon Pharma HZNP:US USD 3.41B 208.92M
Lannett LCI:US USD 264.66M 25.46M
Ligand Pharmaceuticals LGND:US USD 220.43M 23.35M
Novartis NOVN:VX USD 36.95B 1.19B
Pacira Pharmaceuticals PCRX:US USD 533.41M 7.2M
Patterson Companies PDCO:US USD 1.83B 119.55M
Perrigo Ordinary Shares PRGO:US USD 2.58B 68.2M
Phibro Animal Health PAHC:US USD 570.08M 3.85M
Revance Therapeutics RVNC:US USD 415.59M 154.65M
Supernus Pharmaceuticals SUPN:US USD 663.89M 38.77M
Takeda 4502:JP JPY 2.75T 196.1B
Teva Pharmaceutical TEVA:IT USD 11.45B 711M
Xeris Pharmaceuticals Inc XERS:US USD 148.92M 12.29M
Zoetis ZTS:US USD 6.55B 100M